Literature DB >> 6764836

Specific adoptive immunotherapy: experimental basis and future potential.

P D Greenberg, M A Cheever, A Fefer.   

Abstract

Mesh：

Substances：

Year:  1982        PMID： 6764836     DOI： 10.1007/bf02918244

Source DB:  PubMed          Journal:  Surv Immunol Res        ISSN： 0252-9564


× No keyword cloud information.
  29 in total

1.  Models for syngeneic adoptive chemoimmunotherapy of murine leukemias.

Authors:  A Fefer; A B Einstein; M A Cheever; J R Berenson
Journal:  Ann N Y Acad Sci       Date:  1976       Impact factor: 5.691

2.  Enhanced syngeneic tumor destruction by in vivo inhibition of suppressor T cells using anti-I-J alloantiserum.

Authors:  L L Perry; B Benacerraf; R T McCluskey; M I Greene
Journal:  Am J Pathol       Date:  1978-08       Impact factor: 4.307

3.  In vivo effects of murine hybridoma monoclonal antibody in a patient with T-cell leukemia.

Authors:  R A Miller; D G Maloney; J McKillop; R Levy
Journal:  Blood       Date:  1981-07       Impact factor: 22.113

4.  H-2 restriction of adoptive immunotherapy of advanced tumors.

Authors:  P D Greenberg; M A Cheever; A Fefer
Journal:  J Immunol       Date:  1981-06       Impact factor: 5.422

5.  Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts.

Authors:  P L Weiden; N Flournoy; E D Thomas; R Prentice; A Fefer; C D Buckner; R Storb
Journal:  N Engl J Med       Date:  1979-05-10       Impact factor: 91.245

6.  Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts.

Authors:  A B Cosimi; R B Colvin; R C Burton; R H Rubin; G Goldstein; P C Kung; W P Hansen; F L Delmonico; P S Russell
Journal:  N Engl J Med       Date:  1981-08-06       Impact factor: 91.245

7.  Autologous leukemia-specific T-cell-mediated lymphocytotoxicity in patients with acute myelogenous leukemia.

Authors:  S K Lee; R T Oliver
Journal:  J Exp Med       Date:  1978-03-01       Impact factor: 14.307

8.  Long-term culture of human antigen-specific cytotoxic T-cell lines.

Authors:  S Gillis; P E Baker; F W Ruscetti; K A Smith
Journal:  J Exp Med       Date:  1978-10-01       Impact factor: 14.307

9.  Elimination of syngeneic sarcomas in rats by a subset of T lymphocytes.

Authors:  E Fernandez-Cruz; B A Woda; J D Feldman
Journal:  J Exp Med       Date:  1980-10-01       Impact factor: 14.307

10.  Eradication of disseminated murine leukemia by chemoimmunotherapy with cyclophosphamide and adoptively transferred immune syngeneic Lyt-1+2- lymphocytes.

Authors:  P D Greenberg; M A Cheever; A Fefer
Journal:  J Exp Med       Date:  1981-09-01       Impact factor: 14.307
View more
  1 in total

Review 1.  CAR therapy: the CD19 paradigm.

Authors:  Michel Sadelain
Journal:  J Clin Invest       Date:  2015-09-01       Impact factor: 14.808
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.